Description
In Life Sciences, every decision matters across clinical trials, manufacturing, compliance, and commercial performance. Yet broad analytics platforms often lack the industry context needed for confident decision-making. This conversation explores why CXOs are shifting toward industry-first analytics to drive more relevant insights and better outcomes.